Literature DB >> 1398934

Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice.

B A Wu-Hsieh1, G S Lee, M Franco, F M Hofman.   

Abstract

Experimental infection of animals with Histoplasma capsulatum caused a massive macrophage infiltration into the spleen and induced the production of tumor necrosis factor alpha (TNF-alpha) locally. The cytokine was also produced in vitro by peritoneal exudate macrophages exposed to a large inoculum of yeast cells. Depletion of the cytokine by injection of polyclonal sheep anti-TNF-alpha antibody was detrimental to sublethally infected mice. Fungous burdens in the spleens of TNF-alpha-depleted mice were higher than they were in the infected control mice at days 2, 7, and 9 after infection, and the antibody-treated animals succumbed to the infection. Histopathological study of spleen sections revealed that splenic macrophages were not able to control proliferation of intracellular yeasts as a result of TNF-alpha depletion. It seems that TNF-alpha plays a role in early activation of splenic macrophages which is important in controlling the outcome of an infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398934      PMCID: PMC257457          DOI: 10.1128/iai.60.10.4230-4238.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum.

Authors:  J G Smith; D M Magee; D M Williams; J R Graybill
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

2.  Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; D Sharma; M Solotorovsky; R Lafemina; J Balint
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

Authors:  N E Reiner; W Ng; C B Wilson; W R McMaster; S K Burchett
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

5.  Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms.

Authors:  L H Faccioli; G E Souza; F Q Cunha; S Poole; S H Ferreira
Journal:  Agents Actions       Date:  1990-06

6.  Evidence that tumor necrosis factor has an important role in antibacterial resistance.

Authors:  E A Havell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

7.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor.

Authors:  G E Grau; H Heremans; P F Piguet; P Pointaire; P H Lambert; A Billiau; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Lymphocyte-mediated cellular immunity in histoplasmosis.

Authors:  D H Howard; V Otto; R K Gupta
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

10.  Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.

Authors:  R G Titus; B Sherry; A Cerami
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

3.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

4.  T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Infect Dis       Date:  2005-12-05       Impact factor: 5.226

5.  Tumor necrosis factor alpha (TNF-alpha) and sepsis: evidence for a role in host defense.

Authors:  O Rigato; S Ujvari; A Castelo; R Salomão
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

6.  Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.

Authors:  George S Deepe
Journal:  J Interferon Cytokine Res       Date:  2007-06       Impact factor: 2.607

Review 7.  Endemic mycoses in AIDS: a clinical review.

Authors:  J Wheat
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates.

Authors:  T E Lane; B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs.

Authors:  George S Deepe; Reta S Gibbons; A George Smulian
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.